AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...
Pfizer's Lipitor was the leading US prescription drug in 2003 for the third year in a row, with sales of $6.8 billion, up 10.8% ( Table ). Merck's Zocor, with $4.4 billion in 2003 sales and up 7% ...
The Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, saying the evidence backing the drug isn’t strong enough.
This means that Ranbaxy can advance the launch of its generic version of the cholesterol-lowering drug in Australia by 4 months to May 2012 when the patent expires. Ranbaxy is currently fighting a ...
"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop resistance ...
High Cholesterol Levels at a Young Age Significant ... Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk in Men and Mice Feb. 20, 2024 — The drug finasteride, also known as ...